Subject index volume 47

Cancer

Letters,

Elsevier Scientific

47 (1989) Publishers

231-233 Ireland

231 Ltd.

Subject Index Volume

47

acetic acid and ethanol, carcinogenesis in esophagus and forestomach, N-nitrososarcosin ethyl ester rats, thermal burn, 179 2-acetylaminofluorene, butylated hydroxytoluene, nuclear envelope, cytochrome P-450, chemical carcinogenesis, dietary fats, 83 2-acetylaminofluorine, butylated hydroxyanisole, butylated hydroxytoluene, anticarcinogenic properties, liver, 211 actin, melanoma, diagnosis, 29 addiction, training, clinical aspects, service organization, national policy, 159 aflatoxin Bl, natural carotenoids, DNA adduct formation, microsomal activation, modulation, 127 amino acid transport, density regulation, Burkitt lymphoma cells, growth rate, 121 anti-neoplastic drugs, chromosome abberations, 53 antibody response, DFMO, B cells, ornithine decarboxylase, 11 anticarcinogenic properties, 2-acetylaminofluorine, butylated butylated hydroxyanisole , hydroxytoluene, liver, 211 B cells,

DFMO,

ornithine

decarboxylase,

antibody

response, 11 B16 melanoma, L-histidinol, growth-inhibition, phenotypic alterations, differentiation, 193 benzo[a]pyrene, 3-methylcholanthrene, morphological transformation, C3HlOT1/2 cells, N-methyl-N’nitro-N-nitrosoguanidine, 91 benzo[a]pyrene, tannic acid, mutagenesis, 37 bladder infections, genotoxicity of urine, chromosomedamaging, clastogenic, 99 breast cancer cells, prolactin, phenol red, MCF-7, 105 Burkitt lymphoma cells, amino acid transport, density regulation, growth rate, 121 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, 3(methylnitrosamino)propionic acid, 4-(methylnitrosamino)-4-(3-pyridyl)-l-butyric acid, lung adenoma, 111 hydroxyanisole, 2-acetylaminofluorine, butylated butylated hydroxytoluene, anticarcinogenic properties, liver, 211

butylated hydroxytoluene, 2-acetylaminofluorene, nuclear envelope, cytochrome P-450, chemical carcinogenesis, dietary fats, 83 butylated hydroxytoluene, 2-acetylaminofluorine, butylated hydroxyanisole, anticarcinogenic properties, liver, 2 11 4-(methylnitrosamino)-4-(3-pyridyl)butyric acid, 3(methylnitrosamino)propionic acid, 4-(methylnitrosamino)-l-(3-pyridyl)-l-butanone, lung adenoma, 111

C3HlOT1/2 cells, benzo[a]pyrene, S-methylcholanthrene, morphological transformation, N-methylN’-nitro-N-nitrosoguanidine, 91 cancer marker, immunomasking, novel antigen, 199 carcinogenesis in esophagus and forestomach, Nnitrososarcosin ethyl ester - rats, acetic acid and ethanol, thermal burn, 179 CEA, peritoneal washings, gastric cancer, prognostic guide, cytological examination, 79 cellular immunity, interleukin-2, cervix cancer, immunodeficiency, 205 cellular step of initiation, chemical hepatocarcinogenesis, preneoplastic hepatocyte, 163 cervix cancer, interleukin-2, immunodeficiency, cellular immunity, 205 chemical carcinogenesis, 2-acetylaminofluorene, butylated hydroxytoluene, nuclear envelope, cytochrome P-450, dietary fats, 83 chemical hepatocarcinogenesis, cellular step of initiation, preneoplastic hepatocyte, 163 chemoprevention, stomach, diallyl sulfide, MNNG, Wistar rat, 153 chromosome-damaging, genotoxicity of urine, bladder infections, clastogenic, 99 chromosome abberations, anti-neoplastic drugs, 53 clastogenic, genotoxicity of urine, bladder infections, chromosome-damaging, 99 clinical aspects, addiction, training, service organization, national policy, 159 collagenase, plasminogen activator, tumorigenesis, 45

232

colon carcinogenesis, linolic acid, oxidized linolic acid, mammary gland carcinogenesis, 141 compensatory cell proliferation, rat liver, direct mitogen , lead nitrate, protooncogenes, gene expression, 115 Cu(ll) (3,5-diisproopylsalicylate),, protein kinase C, rat liver, 169 cytochrome P-450, 2-acetylaminofluorene, butylated hydroxytoluene, nuclear chemical envelope, carcinogenesis, dietary fats, 83 cytological examination, CEA, peritoneal washings, gastric cancer, prognostic guide, 79 cytosol, mutagenesis, IV-nitrosodimethylamine, mutational specificity, 63 demographic parameters, tritiated thymidine labelling, rectal epithelial proliferation, 133 chemical hepatocarcinogenesis, cellular step of initiation, preneoplastic hepatocyte, 163 amino acid transport, Burkitt density regulation, lymphoma cells, growth rate, 121 DFMO, B cells, ornithine decarboxylase, antibody response, 11 diagnosis, melanoma, actin, 29 diallyl sulfide, stomach, MNNG, Wistar rat, chemoprevention, 153 dietary fats, 2-acetylaminofluorene, butylated hydroxytoluene, nuclear envelope, cytochrome P450, chemical carcinogenesis, 83 differentiation, 5-methylcytosine, Friend erythroleukemia cells, DNA methylation, 149 differentiation, 816 melanoma, L.-histidinol, growthinhibition, phenotypic alterations, 193 direct mitogen, rat liver, compensatory cell proliferation, lead nitrate, protooncogenes, gene expression, 115 DNA adduct formation, natural carotenoids, aflatoxin Bl, microsomal activation, modulation, 127 methylation, 5-methylcytosine, DNA Friend erythroleukemia cells, differentiation, 149 DNA synthesis, peroxisome proliferation, ethoxyquin, hepatomegaly, 21

elongation-block, transcription, oncogene, myc, NFkappa B, 1 ethoxyquin, peroxisome proliferation, hepatomegaly, DNA synthesis, 21 fibrinolytic inhibitor, Guerin epithelioma, rats, 57 erythroleukemia Friend cells, 5-methylcytosine, differentiation, DNA methylation, 149

gastric cancer, CEA, peritoneal washings, prognostic guide, cytological examination, 79 gene expression, rat liver, compensatory cell proliferation, direct mitogen , lead nitrate, protooncogenes, 115 genotoxicity of urine, bladder infections, chromosomedamaging, clastogenic, 99 growth-inhibition, B16 melanoma, L-histidinol, phenotypic alterations, differentiation, 193 growth rate, amino acid transport, density regulation, Burkitt lymphoma cells, 121 Guerin epithelioma, fibrinolytic inhibitor, rats, 57 hepatomegaly, peroxisome proliferation, ethoxyquin, DNA synthesis, 21 t.-histidinol, B16 melanoma, growth-inhibition, phenotypic alterations, differentiation, 193 immunodeficiency, interleukin-2, cervix cancer, cellular immunity, 205 immunomasking, novel antigen, cancer marker, 199 interferons, natural cell mediated cytotoxicity, single cell cytotoxicity assay, interleukin 2, 69 interleukin-2, cervix cancer, immunodeficiency, cellular immunity, 205 interleukin 2, natural cell mediated cytotoxicity, single cell cytotoxicity assay, interferons, 69 lead nitrate, rat liver, compensatory cell proliferation, direct mitogen, protooncogenes, gene expression, 115 linolic acid, oxidized linolic acid, mammary gland carcinogenesis, colon carcinogenesis, 141 liver, 2-acetylaminofluorine, butylated hydroxyanisole, butylated hydroxytoluene, anticarcinogenic properties, 211 lung adenoma, 3-(methylnitrosamino)propionic acid 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, 4(methylnitrosamino)-4-(3-pyridyl)butyric acid, 111 mammary gland carcinogenesis, linolic acid, oxidized linolic acid, colon carcinogenesis, 141 MCF-7, prolactin, phenol red, breast cancer cells, 105 melanoma, actin, diagnosis, 29 3-methylcholanthrene, benzo[a]pyrene, morphological transformation, C3HlOT1/2 cells, N-methyl-N’nitro-N-nitrosoguanidine, 91 5-methylcytosine, Friend erythroleukemia cells, differentiation, DNA methylation, 149 microsomal activation, natural carotenoids, aflatoxin Bl, DNA adduct formation, modulation, 127 MNNG, stomach, diallyl sulfide, Wistar rat, chemoprevention, 153

233 modulation, natural carotenoids, aflatoxin Bl, DNA adduct formation, microsomal activation, 127 morphological transformation, benzo[a]pyrene, 3methylcholanthrene, C3HlOT1/2 cells, N-methylN’-nitro-N-nitrosoguanidine, 91 mutagenesis, N-nitrosodimethylamine, cytosol, mutational specificity, 63 mutagenesis, tannic acid, benzo[a]pyrene, 37 mutational specificity, mutagenesis, N-nitrosodimethylamine, cytosol, 63 myc, transcription, oncogene, elongation-block, NFkappa B, 1 N-methyl-N’-nitro-N-nitrosoguanidine, benzo[a]pyrene, 3-methylcholanthrene, morphological transformation, C3HlOT1/2 cells, 91 N-nitrosodimethylamine, mutagenesis, cytosol, mutational specificity, 63 N-nitrososarcosin ethyl ester - rats, carcinogenesis in and forestomach, esophagus acetic acid and ethanol, thermal burn, 179 national policy, addiction, training, clinical aspects, service organization, 159 natural carotenoids, aflatoxin Bl, DNA adduct formation, microsomal activation, modulation, 127 natural cell mediated cytotoxicity, single cell cytotoxicity assay, interferons, interleukin 2, 69 ,transcription, NF-kappa B, oncogene, myc, elongation-block, 1 novel antigen, immunomasking, cancer marker, 199 nuclear envelope, 2-acetylaminofluorene, butylated hydroxytoluene, cytochrome P-450, chemical carcinogenesis, dietary fats, 83

oncogene, transcription, myc, elongation-block, NFkappa B, 1 ornithine decarboxylase, DFMO, B cells, antibody response, 11 oxidized linolic acid, linolic acid, mammary gland carcinogenesis, colon carcinogenesis, 141 peritoneal washings, CEA, gastric cancer, prognostic guide, cytological examination, 79 peroxisome proliferation, ethoxyquin, hepatomegaly, DNA synthesis, 21 phenol red, prolactin, breast cancer cells, MCF-7, 105 phenotypic alterations, B16 melanoma, histidinol * , growth-inhibition, differentiation, 193 plasminogen activator, collagenase, tumorigenesis, 45 platinum complexes, radiosensitization, platinum (dye) complexes, triaminotriphenylmethanes, 217 platinum (dye) complexes, radiosensitization, platinum complexes, triaminotriphenylmethanes, 217

preneoplastic hepatocyte, chemical hepatocarcinogenesis, cellular step of initiation, 163 prognostic guide, CEA, peritoneal washings, gastric cancer, cytological examination, 79 prolactin, phenol red, breast cancer cells, MCF-7, 105 3-(methylnitrosamino)propionic acid, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, 4-(methylnitrosamino)-4-(3-pyridyl)butyric acid, lung adenoma, 111 protein kinase C, Cu(II) (3,5-diisproopylsalicylate)2, rat liver, 169 protooncogenes, rat liver, compensatory cell proliferation, direct mitogen, lead nitrate, gene expression, 115 radiosensitiiation, platinum complexes, platinum (dye) complexes, triaminotriphenylmethanes, 217 rats, fibrinolytic inhibitor, Guerin epithelioma, 57 rat liver, compensatory cell proliferation, direct mitogen , lead nitrate, protooncogenes, gene expression, 115 rat liver, Cu(l1) (3,5-diispropylsalicylate),, protein kinase C, 169 rat mammary tumor therapy, N-(4-hydroxyphenyl) retinamide, 187 rectal epithelial proliferation, tritiated thymidine labelling, demographic parameters, 133 N-(4-hydroxyphenyl) retinamide, rat mammary tumor therapy, 187 service organization, addiction, training, clinical aspects, national policy, 159 single cell cytotoxicity assay, natural cell mediated cytotoxicity, interferons, interleukin 2, 69 stomach, diallyl sulfide, MNNG, Wistar rat, chemoprevention, 153 tannic acid, benzo[a]pyrene, mutagenesis, 37 thermal burn, carcinogenesis in esophagus and forestomach, N-nitrososarcosin ethyl ester - rats, acetic acid and ethanol, 179 training, addiction, clinical aspects, service organization, national policy, 159 transcription, oncogene, myc, elongation-block, NFkappa B, 1 triaminotriphenylmethanes, radiosensitization, platinum complexes, platinum (dye) complexes, 217 tritiated thymidine labelling, rectal epithelial proliferation, demographic parameters, 133 tumorigenesis, plasminogen activator, collagenase, 45 Wistar rat, stomach, chemoprevention, 153

diallyl

sulfide,

MNNG,